Tuesday, March 17, 2026

From Hair Loss to Inflammation: JW Pharmaceutical Showcases Pipeline to Global Pharma at JPMorgan

JW Pharmaceutical participated in the JP Morgan Healthcare Conference, discussing potential drug partnerships and licensing deals.

‘The Old Woman with the Knife’ Gets Rave Reviews at Berlin Film Fest

"The Old Woman with the Knife," premieres in May after acclaim at Berlinale, featuring a legendary assassin's showdown.

Unification Ministry: Kim Jong-un’s Consecutive Military Activities Aimed At Justifying Nuclear Program And Targeting South Korean Nuclear Submarines

North Korea's military reports, analyzed by the Ministry of Unification, target domestic and international audiences with differing messages.

Tag: Dupixent

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.